Telemedicine Retinal Screening Utilizing a Mobile Medical Unit
NCT01412905
Cardiovascular Diseases, Diabetes
La Jolla, California, United States
View Trial DetailsNCT Number: NCT00828425
Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed:
* which medication are used to keep blood pressure under control? * which medication are used for metabolic control? * the average control level of metabolism and blood pressure is compliant with the international guidelines? * laser photocoagulation plays a role in the control of metabolism and blood pressure? * there are differences in the control of metabolism and blood pressure between patients with DM I or DM II? * there is an influence of renal failure on the choose of medication?
Looking for future studies?
Notify MeAll sexes
Observational
Research Site, Diegten, Basel-Landschaft, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: every 3 months
Time frame: every 3 months
Time frame: every 3 months
AstraZeneca
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01412905
Cardiovascular Diseases, Diabetes
La Jolla, California, United States
View Trial DetailsNCT03901898
Diabetes, Diabetes Mellitus
Cork, Ireland
View Trial DetailsNCT02321904
Autoimmune Diseases, Corneal Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT00259701
Aneurysm, Cardiovascular Diseases
New Haven, Connecticut, United States
View Trial Details